Testing effectiveness (Phase 2)WithdrawnNCT03028909
What this trial is testing
Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
Who this might be right for
Influenza - Type A Strains
MedImmune LLC